Berry Genomics Co.,Ltd (SHE:000710)

Market Cap	4.53B
Revenue (ttm)	973.82M
Net Income (ttm)	-228.93M
Shares Out	353.52M
EPS (ttm)	-0.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,522,100
Average Volume	16,376,511
Open	13.70
Previous Close	13.00
Day's Range	12.77 - 13.70
52-Week Range	7.39 - 19.55
Beta	0.44
RSI	34.21
Earnings Date	Aug 30, 2025

About Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 1,402
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000710

Financial Performance

In 2024, Berry Genomics Co.,Ltd's revenue was 1.08 billion, a decrease of -6.36% compared to the previous year's 1.15 billion. Losses were -192.43 million, -54.96% less than in 2023.